Allergy Therapeutics plc
AGY.L · LSE
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | £13 | £22 | £13 | £14 |
| Short-Term Investments | £0 | £0 | £0 | £0 |
| Receivables | £8 | £9 | £8 | £10 |
| Inventory | £14 | £12 | £13 | £12 |
| Other Curr. Assets | £0 | £0 | £0 | £0 |
| Total Curr. Assets | £35 | £42 | £33 | £35 |
| Property Plant & Equip (Net) | £24 | £23 | £24 | £23 |
| Goodwill | £3 | £3 | £3 | £3 |
| Intangibles | £1 | £1 | £1 | £2 |
| Long-Term Investments | £0 | £0 | £0 | £0 |
| Tax Assets | £2 | £0 | £0 | £0 |
| Other NC Assets | £3 | £3 | £3 | £5 |
| Total NC Assets | £33 | £31 | £31 | £34 |
| Other Assets | £0 | £0 | £0 | £0 |
| Total Assets | £68 | £73 | £65 | £69 |
| Liabilities | – | – | – | – |
| Payables | £4 | £14 | £4 | £20 |
| Short-Term Debt | £2 | £3 | £2 | £2 |
| Tax Payable | £1 | £0 | £5 | £0 |
| Deferred Revenue | £0 | £0 | £0 | £0 |
| Other Curr. Liab. | £19 | £9 | £10 | £3 |
| Total Curr. Liab. | £27 | £26 | £21 | £25 |
| LT Debt | £58 | £43 | £29 | £8 |
| Deferred Rev, NC | £0 | £0 | £0 | £0 |
| Deferred Tax Liab, NC | £0 | £0 | £0 | £0 |
| Other NC Liab. | £10 | £11 | £11 | £9 |
| Total NC Liab. | £69 | £54 | £41 | £17 |
| Other Liabilities | £0 | £0 | £0 | £0 |
| Cap. Leases | £7 | £7 | £8 | £8 |
| Total Liabilities | £96 | £80 | £61 | £43 |
| Equity | – | – | – | – |
| Pref Stock | £0 | £0 | £0 | £0 |
| Common Stock | £5 | £5 | £5 | £5 |
| Retained Earnings | -£195 | -£170 | -£199 | -£175 |
| AOCI | £5 | £2 | £43 | £42 |
| Other Equity | £157 | £156 | £155 | £155 |
| Total Equity | -£28 | -£7 | £4 | £26 |
| Supplemental Information | – | – | – | – |
| Minority Interest | £0 | £0 | £0 | £0 |
| Total Liab. & Tot. Equity | £68 | £73 | £65 | £69 |
| Net Debt | £47 | £24 | £18 | -£4 |